CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

被引:1323
作者
Jaiswal, Siddhartha [1 ,2 ]
Jamieson, Catriona H. M. [3 ]
Pang, Wendy W. [1 ,2 ]
Park, Christopher Y. [1 ,2 ]
Chao, Mark P. [1 ,2 ]
Majeti, Ravindra [1 ,2 ]
Traver, David [4 ]
van Rooijen, Nico [5 ]
Weissman, Irving L. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Ludwig Ctr Stanford, Stanford Canc Ctr,Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[3] Univ Calif San Diego, Moores UCSD Canc Ctr, Stem Cell Res Program, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA
[5] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands
基金
美国国家卫生研究院;
关键词
INTEGRIN-ASSOCIATED PROTEIN; COLONY-STIMULATING FACTOR; MYELOID PROGENITORS; EXPRESSION; MOBILIZATION; BLOOD; ENGRAFTMENT; RECEPTOR; MARKER; MICE;
D O I
10.1016/j.cell.2009.05.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages clear pathogens and damaged or aged cells from the blood stream via phagocytosis. Cell-surface CD47 interacts with its receptor on macrophages, SIRP alpha, to inhibit phagocytosis of normal, healthy cells. We find that mobilizing cytokines and inflammatory stimuli cause CD47 to be transiently upregulated on mouse hematopoietic stem cells (HSCs) and progenitors just prior to and during their migratory phase, and that the level of CD47 on these cells determines the probability that they are engulfed in vivo. CD47 is also constitutively upregulated on mouse and human myeloid leukemias, and overexpression of CD47 on a myeloid leukemia line increases its pathogenicity by allowing it to evade phagocytosis. We conclude that CD47 upregulation is an important mechanism that provides protection to normal HSCs during inflammation-mediated mobilization, and that leukemic progenitors co-opt this ability in order to evade macrophage killing.
引用
收藏
页码:271 / 285
页数:15
相关论文
共 42 条
[1]   A clonogenic common myeloid progenitor that gives rise to all myeloid lineages [J].
Akashi, K ;
Traver, D ;
Miyamoto, T ;
Weissman, IL .
NATURE, 2000, 404 (6774) :193-197
[2]   Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning [J].
Bhattacharya, D ;
Rossi, DJ ;
Bryder, D ;
Weissman, IL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (01) :73-85
[3]   CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells [J].
Blazar, BR ;
Lindberg, FP ;
Ingulli, E ;
Panoskaltsis-Mortari, A ;
Oldenborg, PA ;
Iizuka, K ;
Yokoyama, WM ;
Taylor, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :541-549
[4]   Integrin-associated protein (CD47) and its ligands [J].
Brown, EJ ;
Frazier, WA .
TRENDS IN CELL BIOLOGY, 2001, 11 (03) :130-135
[5]  
CAMPBELL IG, 1992, CANCER RES, V52, P5416
[6]   α-Pal/NRF-1 regulates the promoter of the human integrin-associated protein/CD47 gene [J].
Chang, WT ;
Huang, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :14542-14550
[7]   Circulation and chemotaxis of fetal hematopoietic stem cells [J].
Christensen, JL ;
Wright, DE ;
Wagers, AJ ;
Weissman, IL .
PLOS BIOLOGY, 2004, 2 (03) :368-377
[8]  
CLINE MJ, 1977, EXP HEMATOL, V5, P186
[9]   Ontogeny of the hematopoietic system [J].
Cumano, Ana ;
Godin, Isabelle .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :745-785
[10]   LPS-binding proteins and receptors [J].
Fenton, MJ ;
Golenbock, DT .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (01) :25-32